Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of misleading practices related to Medicare insurance plans, with a deadline for investors to seek lead plaintiff status in a federal class action by October 10, 2025 [2][4]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, rather than providing unbiased comparisons [4]. - SelectQuote is accused of receiving illegal kickbacks from health insurance companies to steer beneficiaries towards certain plans, which may have violated federal laws [4][5]. - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021, leading to a significant drop in the company's stock price by 19.2% on May 1, 2025 [5]. Group 2: Legal Proceedings and Investor Actions - Investors who suffered losses exceeding $75,000 in SelectQuote between September 9, 2020, and May 1, 2025, are encouraged to discuss their legal options with Faruqi & Faruqi [1]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the ability to direct and oversee the litigation [6]. - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding SelectQuote's conduct [7].
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuote